1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival outcomes and prognostic factors for gastric cancer in the adjuvant setting: An analysis of the National Cancer Database
    Meeting Abstract

    Nguy, S.; Wu, P.; Lee, A.; Tam, M.; Schreiber, D.; Du, K. L.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Lack of validation of lymphopenia as a prognostic factor in esophageal cancer chemoradiation
    Meeting Abstract

    Zhang, M.; Oh, P.; Brady, P.; Ilson, D. H.; Janjigian, Y.; Ku, G.; Crane, C. H.; Jackson, A.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Oncofertility patient advocacy: Speak up, make Change
    Meeting Abstract

    Thompson, M.
    Fertility and Sterility (2018)

    Fulltext@MSK | Save
  • Acetaminophen immediate release pharmacokinetics in iatrogenic overdose
    Meeting Abstract

    Yip, L.; Dart, R. C.; Spyker, D. A.; Chapman, P. B.
    Clinical Toxicology (2018)

    Fulltext@MSK | Save
  • Dosimetry of LUTATHERA in patients with advanced midgut neuroendocrine tumors: Results of the phase III NETTER-1 sub-study
    Meeting Abstract

    Bodei, L.; Cremonesi, M.; Ferrari, M.; Krenning, E.; Sierra, M. L.; Erion, J. L.; Santoro, P.; Chicco, D.; Mariani, M. F.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Combined 177Lu-DOTATATE and metronomic capecitabine in gastro-entero-pancreatic neuroendocrine tumors with high glucose metabolism: Preliminary data of a phase II prospective trial
    Meeting Abstract

    Paganelli, G.; Nicolini, S.; Grana, C. M.; Bodei, L.; Di Mauro, F.; Tardelli, E.; Monti, M.; Ferroni, F.; Caroli, P.; Ibrahim, T.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Comparison of (68)Ga-DOTA-JR11 PET/CT with (dosimetric) (177)Lu-DOTA-JR11 SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
    Meeting Abstract

    Krebs, S.; O'Donoghue, J.; Biegel, E.; Beattie, B. J.; Reidy, D.; Bodei, L.; Weber, W. A.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • MIRDcalc Internal dosimetry software: Initial development and validation
    Meeting Abstract

    Kesner, A. L.; Olguin, E.; Zanzonico, P.; Lafontaine, D.; Bolch, W. E.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Renal protection during LUTATHERA treatment using lysine and arginine solutions
    Meeting Abstract

    Bodei, L.; Cremonesi, M.; Ferrari, M.; Krenning, E.; Sierra, M. L.; Erion, J. L.; Santoro, P.; Chicco, D.; Mariani, M. F.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic merkel cell carcinoma (mMCC) progressed on chemotherapy
    Meeting Abstract

    van Hagen, T.; Sandhu, S.; Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; more...
    Asia-Pacific Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save